SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?


To: Miljenko Zuanic who wrote (1927)1/27/2002 10:17:44 PM
From: seminole  Respond to of 2515
 
OT

The biweekly schedule study (D1-D15) recommended a dose of 24mg/m^2
during a 30 minute infusion (ASCO 2001, abstract 214).
The original daily x5 schedule (MGI) was found to be inferior to a daily x4 schedule (NCI)
in parallel phase II ovarian studies as reported at ASCO (2000).